PTC Therapeutics, Inc. (PTCT)
70.66
+0.76
(+1.09%)
USD |
NASDAQ |
Feb 20, 16:00
70.59
-0.07
(-0.10%)
After-Hours: 20:00
PTC Therapeutics Shareholders Equity (Quarterly) : -205.31M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 6.057B |
| Sarepta Therapeutics, Inc. | 1.320B |
| Ardelyx, Inc. | 166.95M |
| Spyre Therapeutics, Inc. | 715.24M |
| Ovid Therapeutics, Inc. | 44.70M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.911B |
| Total Liabilities (Quarterly) | 3.117B |
| Debt to Equity Ratio | -1.942 |
| Current Ratio | 2.348 |
| Net Debt Paydown Yield | 0.00% |